Abstract
Introduction: This short report describes the results of a survey that was developed by Public Health England (PHE), the British HIV Association (BHIVA) and the Children's HIV Association (CHIVA) and circulated to all UK national health service HIV providers in the UK following the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; coronavirus disease 2019 [COVID-19]) pandemic to assess the impact of the pandemic on HIV clinics.
Methods: The survey was created by BHIVA/CHIVA and PHE and was piloted prior to circulation to all HIV clinics within the UK on 3 July 2020. The survey questions were designed to assess the impact of the first wave of COVID-19 on HIV clinics and lead/senior HIV clinicians. Clinicians’ responses were collected between 3 July 2020 and 17 September 2020. The survey responses were collated, and non-statistical analysis was performed.
Results: The results of the survey confirmed that services had undergone substantial changes, including a shift from face-to-face consults to predominantly virtual consultations. Some clinicians’ responses suggested that the first wave had many negative effects on people living with HIV, including their ability to access mental health services.
Conclusion: The first wave of COVID-19 caused significant changes to HIV services within the UK. There was a shift toward the use of technology in healthcare, and results from subsequent clinician surveys carried out since the first wave of COVID-19 will reflect the ongoing transformation of care towards a more virtual service.
Original language | English |
---|---|
Pages (from-to) | 1098-1102 |
Number of pages | 5 |
Journal | HIV Medicine |
Volume | 23 |
Issue number | 10 |
Early online date | 28 Mar 2022 |
DOIs | |
Publication status | E-pub ahead of print - 28 Mar 2022 |
Bibliographical note
Funding Information: Dr David Asboe has received payment for attending advisory boards for Viiv. Dr Jane Anderson has received consultancy and speaker fees from Gilead Sciences and speaker fees from ViiV. Dr Laura Waters is an investigator on trials sponsored by Gilead, ViiV and Janssen and has received speaker/advisory fees from Gilead, ViiV, Janssen, MSD, Theratech, Cipla and Mylan. Gabriella Shanks, Ammi Shah, Amanda Williams, Valerie Delpech and Amanda Ely have no conflicts of interest that are directly relevant to the content of this article.Open Access: Free to read, but no Open Access licence.
Publisher Copyright: © 2022 British HIV Association.
Citation: Shanks, G, Shah, A, Williams, A, et al. Covid-19 First Wave Impact National Survey for HIV Clinicians by Public Health England (PHE), the British HIV Association (BHIVA) and the Children’s HIV Association (CHIVA). HIV Med. 2022; 00: 1– 5.
DOI: 10.1111/hiv.13307
Keywords
- COVID-19
- HIV
- pandemic
- services